The PROTECTS Act of 2025 prohibits the use of federal funds for gender transition surgeries, hormone therapies, and puberty blockers for minors, with specific medical exceptions.
Rich McCormick
Representative
GA-7
The PROTECTS Act of 2025 prohibits the use of federal funds to provide, refer, or reimburse gender transition procedures—including surgeries, hormone therapies, and puberty blockers—for individuals under the age of 18. The bill includes specific exceptions for medically necessary treatments related to genetic disorders of sex development or other physical health conditions.
The PROTECTS Act of 2025 seeks to cut off all federal financial support for gender transition procedures for anyone under the age of 18. This isn't just a ban on direct payments; it also prohibits federal funds from being used to refer a minor for these procedures or to reimburse any clinic or hospital that provides them. The bill specifically targets a wide range of medical interventions, from surgeries like mastectomies and facial reconstruction to prescriptions for puberty blockers and hormone therapies at levels exceeding natural biological production. If a doctor uses federal resources to help a teenager access these treatments, that funding could be stripped under Section 2 of the act.
The list of prohibited procedures is extensive and covers almost every surgical or chemical intervention currently used for gender affirmation. We’re talking about everything from common surgeries to specific medications like GnRH analogues used to pause puberty. For a family relying on federal programs like Medicaid or CHIP, this could mean that treatments previously covered are suddenly out of reach financially. The bill also includes a catch-all for any plastic or cosmetic surgery intended to feminize or masculinize features, which could create a gray area for doctors who perform reconstructive surgeries that might be interpreted as 'masculinizing' or 'feminizing' even if the primary goal is different.
There are specific 'safety valves' built into the bill. Under Section 2, federal funds can still be used for minors dealing with precocious puberty or medically verifiable genetic disorders of sex development (often referred to as intersex conditions). However, the bill is very specific about who qualifies for what: it defines 'male' and 'female' strictly based on the reproductive system's capacity to produce sperm or eggs. This rigid definition might complicate care for individuals whose biological reality doesn't fit neatly into those two boxes. Additionally, while there is an exception for procedures needed to save a minor's life, the bill explicitly states that this does not include procedures intended to alleviate mental distress, effectively separating physical emergencies from mental health crises.
For healthcare providers, this bill introduces a significant layer of administrative risk. A pediatrician working at a federally funded community health center, for example, would have to be extremely careful about making referrals for a transgender patient to avoid jeopardizing the clinic's entire federal budget. For parents, this could mean a sudden loss of access to specialists who rely on federal grants or insurance programs. Because the bill also bars 'referrals,' it could potentially limit the information doctors are allowed to share with families during a consultation if that doctor’s salary is paid through federal funds. This creates a situation where the type of medical advice you receive might depend entirely on how your doctor’s office is funded.